Literature DB >> 21653601

Human immunodeficiency virus infection is associated with accelerated atherosclerosis.

Giovanni Guaraldi1, Stefano Zona, Gabriella Orlando, Federica Carli, Guido Ligabue, Federica Fiocchi, Marianna Menozzi, Rosario Rossi, Maria Grazia Modena, Paolo Raggi.   

Abstract

OBJECTIVES: Cardiovascular risk is increased in HIV-infected individuals compared with the general population, making HIV disease an ideal model to investigate the pathogenesis and natural history of atherosclerosis. In this pilot study, we compared the progression of coronary artery calcium (CAC) between HIV-infected and uninfected patients.
METHODS: Atherosclerosis progression was assessed in 25 HIV-infected men and 13 HIV-negative controls by means of sequential CAC scans using CT. A CAC score progression ≥ 15%/year was used as a surrogate marker of increased risk of cardiovascular events.
RESULTS: During a median follow-up of 11 months, a CAC score increase ≥ 15%/year was detected in 14 HIV-infected patients (56%) and 4 HIV-negative individuals (31%). HIV infection, age and hypercholesterolaemia were independently associated with a CAC score increase ≥ 15%/year in an adjusted Cox regression model.
CONCLUSIONS: HIV infection, age and hypercholesterolaemia were independently associated with CAC progression. HIV as well as traditional risk factors contribute to accelerate atherosclerosis in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653601     DOI: 10.1093/jac/dkr206

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

Review 1.  Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy.

Authors:  Ramona Bhatia; Patrick Ryscavage; Babafemi Taiwo
Journal:  J Neurovirol       Date:  2011-12-29       Impact factor: 2.643

2.  Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome.

Authors:  Kathleen Fitch; Suhny Abbara; Hang Lee; Eleni Stavrou; Rachel Sacks; Theresa Michel; Linda Hemphill; Martin Torriani; Steven Grinspoon
Journal:  AIDS       Date:  2012-03-13       Impact factor: 4.177

3.  Effects of aging and smoking on carotid intima-media thickness in HIV-infection.

Authors:  Kathleen V Fitch; Sara E Looby; Alison Rope; Peace Eneh; Linda Hemphill; Hang Lee; Steven K Grinspoon
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

Review 4.  HIV-1, reactive oxygen species, and vascular complications.

Authors:  Kristi M Porter; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2012-04-21       Impact factor: 7.376

5.  Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.

Authors:  Josip Begovac; Gordana Dragović; Klaudija Višković; Jovana Kušić; Marta Perović Mihanović; Davorka Lukas; Đorđe Jevtović
Journal:  Croat Med J       Date:  2015-02       Impact factor: 1.351

Review 6.  The Role of Caveolin 1 in HIV Infection and Pathogenesis.

Authors:  Ayalew Mergia
Journal:  Viruses       Date:  2017-05-26       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.